AI tools for scientists: One platform to rule workflows, not models

Scientists juggle databases, pipelines, and tools every day. A new AI platform wants to simplify that chaos. Called Claude Science, it’s not a smarter AI model. It’s a single workspace where researchers can pull data, run experiments, and generate results without jumping between apps. The system connects to over 60 scientific databases and offers ready-to-use toolkits for fields like genomics and chemistry. Think of it as a project manager that can also split tasks among specialized AI helpers. The platform runs on the same models everyone already uses—like Claude Opus 4. 8. No hidden upgrades or special access. But it adds a built-in fact-checker to catch fake citations and math errors before publication. It also saves work by generating code, figures, and 3D models together. If a scientist tweaks a figure using plain language, the system updates the code behind the scenes. And it keeps data local, running on a lab’s own servers instead of sending everything to a cloud.

Early adopters are already seeing results. A genome browser was built from scratch in days. Another user created a multi-agent review system for neuroscience data. These examples suggest the tool could speed up routine tasks without requiring new AI breakthroughs. That’s a key shift: instead of chasing model power, the focus is on making existing tools work better together. Not everyone is taking the same approach. OpenAI launched a specialized biology model called GPT-Rosalind, but it’s limited to vetted enterprise customers. Google DeepMind, meanwhile, owns core science models like AlphaFold and bundles them into a platform with over 30 databases. These different strategies show how AI companies are betting on access, not just capability. Claude Science is open now in beta for paying users. Anthropic is also offering grants for academic projects, with up to $30, 000 in credits for postdocs and grad students. The goal? To see how far workflow-focused tools can go in fields like biomedicine. How this plays out could shape how AI is sold in other specialized fields—from law to engineering.

Actions